NEW YORK--(BUSINESS WIRE)--NeoStem, Inc. (OTCBB:NEOI - News), the first company to specialize in the collection, processing and storage of stem cells from healthy adult donors for personal use in times of critical medical need, invites investors to review an investor presentation highlighting the Company’s visionary business model targeting the projected $8.5 billion stem cell therapeutics industry.
